Richard A. King
( out of 43 reviews )

Richard A. King, MD

Languages spoken: English

Clinical Locations

Sugar House Health Center

Salt Lake City
801-581-2000
Directions

  • Dr. Richard King is an assistant professor in the division of hematology and hematologic malignancies at the University of Utah. He earned his medical degree at the Ohio State University, then completed his internal medicine residency and his hematology and oncology fellowship at the University of Michigan. He specializes in nonmalignant hematologic disorders. His clinical interests include congenital and acquired anemia, bone marrow failure syndromes, porphyria, iron disorders, and platelet disorders. His research has focused on congenital dyserythropoietic anemias with the goal of better understanding the mechanisms of these disorders to lead to new treatments.

    Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)
    National Board of Medical Examiners

    Patient Rating

    4.9 /5
    ( out of 43 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    January 22, 2025
    SUGAR HOUSE HEALTH CENTER

    My first meeting with Dr. King was pleasant and professional. He is a perceptive and patient listener and professional competent communicator. I'm looking forward to having his expert advice and counsel.

    January 19, 2025
    SUGAR HOUSE HEALTH CENTER

    Thank you

    December 30, 2024
    SUGAR HOUSE HEALTH CENTER

    He is great to talk with. Explains things so its easy to understand. He explains the next steps you will take and has time for your questions

    December 29, 2024
    SUGAR HOUSE HEALTH CENTER

    Excellent care and communication.

    November 09, 2024
    SUGAR HOUSE HEALTH CENTER

    Listened to my concerns with empathy and understanding and developed a diagnostic plan to address those concerns,

    October 16, 2024
    SUGAR HOUSE HEALTH CENTER

    Recommend

    September 01, 2024
    SUGAR HOUSE HEALTH CENTER

    Dr. King wa an absolute pleasure to work with; professional, listened extremely well, and included my concerns in planning. Highly recommended.

    July 27, 2024
    SUGAR HOUSE HEALTH CENTER

    What a very pleasing, kind, soft person who listened and engaged. Answered all questions, and did so with patience. Highly, highly recommend to anyone needing a Hematologist.

    July 17, 2024
    SUGAR HOUSE HEALTH CENTER

    Like the way he explained things

  • Dr. Richard King is an assistant professor in the division of hematology and hematologic malignancies at the University of Utah. He earned his medical degree at the Ohio State University, then completed his internal medicine residency and his hematology and oncology fellowship at the University of Michigan. He specializes in nonmalignant hematologic disorders. His clinical interests include congenital and acquired anemia, bone marrow failure syndromes, porphyria, iron disorders, and platelet disorders. His research has focused on congenital dyserythropoietic anemias with the goal of better understanding the mechanisms of these disorders to lead to new treatments.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Assistant Professor (Clinical)
    Academic Divisions Hematology & Hematologic Malignancies
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)
    National Board of Medical Examiners

    Education history

    Fellowship Hematology/Oncology - University of Michigan Health System Fellow
    Residency Internal Medicine - University of Michigan Health System Resident
    Professional Medical Medicine - Ohio State University College of Medicine M.D.
    Undergraduate Major: Biomedical Engineering; Minor: Mathematics - University of Cincinnati B.S.

    Selected Publications

    Journal Article

    1. King R, Schaefer J, Sahai V, Griffith KA, Sood SL (2022). Retrospective Cohort Analysis of Aspirin Use and Venous Thromboembolism in Patients with Pancreatic Cancer and an Indwelling Central Venous Catheter. TH Open, 6(3), e221-e229. (Read full article)
    2. King R, Lin Z, Balbin-Cuesta G, Myers G, Friedman A, Zhu G, McGee B, Saunders TL, Kurita R, Nakamura Y, Engel JD, Reddy P, Khoriaty R (2021). SEC23A rescues SEC23B-deficient congenital dyserythropoietic anemia type II. Sci Adv, 7(48), eabj5293. (Read full article)
    3. Kim S, Khoriaty R, Li L, McClune M, Kalfa TA, Wu J, Peltier D, Fujiwara H, Sun Y, Oravecz-Wilson K, King RA, Ginsburg D, Reddy P (2020). ER-to-Golgi transport and SEC23-dependent COPII vesicles regulate T cell alloimmunity. J Clin Invest, 131(2). (Read full article)
    4. Lin Z, King R, Tang V, Myers G, Balbin-Cuesta G, Friedman A, McGee B, Desch K, Ozel AB, Siemieniak D, Reddy P, Emmer B, Khoriaty R (2020). The Endoplasmic Reticulum Cargo Receptor SURF4 Facilitates Efficient Erythropoietin Secretion. Mol Cell Biol, 40(23). (Read full article)
    5. Reid JH, Durant KM, Chen SL, Perissinotti AJ, King R, Khoriaty R, Marini BL (2020). Role of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura. J Oncol Pharm Pract, 26(7), 1695-1702. (Read full article)
    6. Oren L, Khosla S, Murugappan S, King R, Gutmark E (2009). Role of subglottal shape in turbulence reduction. Ann Otol Rhinol Laryngol, 118(3), 232-40. (Read full article)

    Review

    1. King RA, Khoriaty R (2025). Hereditary disorders of ineffective erythropoiesis. [Review]. Blood Cells Mol Dis, 111, 102910. (Read full article)
    2. King R, Gallagher PJ, Khoriaty R (2021). The congenital dyserythropoieitic anemias: genetics and pathophysiology. [Review]. Curr Opin Hematol, 29(3), 126-136. (Read full article)